Literature DB >> 26131195

Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study.

Cuihong Zhu1, Xingshun Qi1, Hongyu Li1, Ying Peng1, Junna Dai1, Jiang Chen1, Chunlian Xia1, Yue Hou1, Wenwen Zhang1, Xiaozhong Guo1.   

Abstract

Hyaluronic acid (HA), laminin (LN), amino-terminal pro-peptide of type III pro-collagen (PIIINP), and collagen IV (CIV) are four major serum markers of liver fibrosis. This retrospective cross-sectional study aimed to evaluate the correlations of the four serum markers with the severity of liver dysfunction in cirrhotic patients. Between January 2013 and June 2014, a total of 228 patients with a clinical diagnosis with liver cirrhosis and without malignancy underwent the tests of HA, LN, PIIINP, and CIV levels. Laboratory data were collected. Child-Pugh and model for the end-stage of liver diseases (MELD) scores were calculated. Of them, 32%, 40%, and 18% had Child-Pugh class A, B, and C, respectively. MELD score was 7.58±0.50. HA (coefficient r: 0.1612, P=0.0203), LN (coefficient r: 0.2445, P=0.0004), and CIV (coefficient r: 0.2361, P=0.0006) levels significantly correlated with Child-Pugh score, but not PIIINP level. Additionally, LN (coefficient r: 0.2588, P=0.0002) and CIV (coefficient r: 0.1795, P=0.0108) levels significantly correlated with MELD score, but not HA or PIIINP level. In conclusions, HA, LN, and CIV levels might be positively associated with the severity of liver dysfunction in cirrhotic patients. However, given a relatively weak correlation between them, our findings should be cautiously interpreted and further validated.

Entities:  

Keywords:  Child-Pugh; Liver; MELD; cirrhosis; fibrosis

Year:  2015        PMID: 26131195      PMCID: PMC4483917     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.

Authors:  J G McHutchison; L M Blatt; M de Medina; J R Craig; A Conrad; E R Schiff; M J Tong
Journal:  J Gastroenterol Hepatol       Date:  2000-08       Impact factor: 4.029

Review 2.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

3.  Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis.

Authors:  J N Plevris; G H Haydon; K J Simpson; R Dawkes; C A Ludlum; D J Harrison; P C Hayes
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-10       Impact factor: 2.566

4.  Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D.

Authors:  Gülseren Seven; Senem Ceren Karatayli; S Kenan Köse; Mustafa Yakut; Gökhan Kabaçam; Murat Törüner; Aylin Okçu Heper; Michael Voelker; Esra Erden; A Mithat Bozdayi; Ozden Uzunalımoğlu; Hakan Bozkaya; Cihan Yurdaydin; Detlef Schuppan
Journal:  Turk J Gastroenterol       Date:  2011-06       Impact factor: 1.852

5.  Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

Authors:  Y Murawaki; Y Ikuta; K Okamoto; M Koda; H Kawasaki
Journal:  J Gastroenterol       Date:  2001-06       Impact factor: 7.527

Review 6.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].

Authors:  Yong-peng Chen; Xiao-rong Feng; Lin Dai; Hong-bing Ding; Lian Zhang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-04

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

Review 9.  [Non-invasive methods for the evaluation of liver fibrosis in clinical practice].

Authors:  M Friedrich-Rust; J Vermehren
Journal:  Z Gastroenterol       Date:  2013-01-11       Impact factor: 2.000

Review 10.  Non-invasive assessment of liver fibrosis.

Authors:  Vasilios Papastergiou; Emmanuel Tsochatzis; Andrew K Burroughs
Journal:  Ann Gastroenterol       Date:  2012
View more
  13 in total

1.  D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study.

Authors:  Yun Li; Xingshun Qi; Hongyu Li; Junna Dai; Han Deng; Jing Li; Ying Peng; Xu Liu; Xiaolin Sun; Xiaozhong Guo
Journal:  Exp Ther Med       Date:  2016-11-28       Impact factor: 2.447

2.  Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis.

Authors:  Gloria Sanchez-Antolín; Carolina Almohalla-Alvarez; Pilar Bueno; Raquel Almansa; Verónica Iglesias; Lucia Rico; Alicia Ortega; Eva Muñoz-Conejero; Felix García-Pajares; Jesus F Bermejo-Martin
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

3.  Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study.

Authors:  Han Deng; Xingshun Qi; Ying Peng; Jing Li; Hongyu Li; Yongguo Zhang; Xu Liu; Xiaolin Sun; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2015-12-20

4.  Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study.

Authors:  Xingshun Qi; Xu Liu; Yongguo Zhang; Yue Hou; Linan Ren; Chunyan Wu; Jiang Chen; Chunlian Xia; Jiajun Zhao; Di Wang; Yanlin Zhang; Xia Zhang; Hao Lin; Hezhi Wang; Jinling Wang; Zhongmin Cui; Xueyan Li; Han Deng; Feifei Hou; Ying Peng; Xueying Wang; Xiaodong Shao; Hongyu Li; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-08-02

5.  Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients.

Authors:  Xingshun Qi; Guohong Han; Chun Ye; Yongguo Zhang; Junna Dai; Ying Peng; Han Deng; Jing Li; Feifei Hou; Zheng Ning; Jiancheng Zhao; Xintong Zhang; Ran Wang; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-07-19

6.  Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Authors:  Huixian Han; Han Deng; Tao Han; Haitao Zhao; Feifei Hou; Xingshun Qi
Journal:  Med Sci Monit       Date:  2017-07-09

7.  Prevalence and Clinical Characteristics of Spontaneous Splenorenal Shunt in Liver Cirrhosis: A Retrospective Observational Study Based on Contrast-Enhanced Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) Scans.

Authors:  Xingshun Qi; Xiaolong Qi; Yongguo Zhang; Xiaodong Shao; Chunyan Wu; Yongji Wang; Ran Wang; Xintong Zhang; Han Deng; Feifei Hou; Jing Li; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2017-05-25

8.  Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study.

Authors:  Xintong Zhang; Xingshun Qi; Valerio De Stefano; Feifei Hou; Zheng Ning; Jiancheng Zhao; Ying Peng; Jing Li; Han Deng; Hongyu Li; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-03-24

9.  Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study.

Authors:  Xingshun Qi; Hongyu Li; Jiang Chen; Chunlian Xia; Ying Peng; Junna Dai; Yue Hou; Han Deng; Jing Li; Xiaozhong Guo
Journal:  Gastroenterol Res Pract       Date:  2015-12-06       Impact factor: 2.260

10.  Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-β1/Smad signaling pathway.

Authors:  Shi-Pin Wu; Zhi Yang; Fu-Rong Li; Xiao-Di Liu; Hong-Tao Chen; Dong-Na Su
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.